Zydus Wellness Limited has informed the Exchange about Investor Presentation
ZYDUSWELL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Wellness reported Q2 FY26 net sales of ₹6,429 million, up 31% year-on-year, and H1 FY26 net sales of ₹15,006 million, up 12.8%. Revenue from operations stood at ₹6,505 million for the quarter and ₹15,114 million for the half-year. Gross contribution margin improved to 52.4% in Q2 from 47.5% last year, supported by lower input costs on sucralose, stevia, and milk. However, EBITDA margin slipped to 3.5% (from 4.0%), and the company posted a loss at the PAT level (₹-528 million in Q2, ₹751 million in H1) due to a low-cost bridge loan for the Comfort Click acquisition, higher amortization, and one-time acquisition costs. Sales were also impacted by the GST 2.0 transition and an early, prolonged monsoon that hit seasonal categories.
For shareholders, the quarter shows strong topline growth and gross margin recovery driven by favorable input costs, but bottom-line pressure from acquisition-related costs and seasonal headwinds remains a near-term concern. The Comfort Click acquisition is described as cash EPS-accretive excluding one-time costs, and management highlights long-term growth runway in international markets and the protein/nutrition segment, which could support investor sentiment despite the Q2 loss.